X4 PharmaceuticalsXFOR
那斯達克 · USD
3.81
+0.08
(+2.01%)
盤中 06/12 12:19 (UTC+8)
06/12 12:19 (UTC+8)
X4 PharmaceuticalsXFOR
3.81
+0.08
(+2.01%)
財務數據
損益表
- -
- -
- 0.01
- 0.01
- 0.01
- 0.29
- 0.02
- 0.02
- 0.03
- 0.03
- -
- -
- -
- -0.53
- 156.07
- 1908.86
- -93.15
- -10.54
- 45.50
- 5.45
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 2,708 | 2,568 | 1,765 | 1,973 | 28,807 | 1,434 | 560 | 563 | - | - |
營業成本 | 598 | 364 | 351 | 326 | 4,716 | 302 | 227 | 268 | - | - |
營業毛利 | 2,110 | 2,204 | 1,414 | 1,647 | 24,091 | 1,132 | 333 | 295 | - | - |
營業費用 | 22,416 | 25,903 | 28,923 | 27,879 | 33,534 | 36,847 | 34,833 | - | - | 25,199 |
研發費用 | 15,450 | 18,521 | 17,337 | 18,352 | 18,513 | 21,702 | 19,173 | 20,914 | 19,854 | 15,272 |
推銷及管理費用 | 6,966 | 7,382 | 11,586 | 9,527 | 15,021 | 15,145 | 15,660 | -91,722 | 17,435 | 9,927 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -20,306 | -23,699 | -27,509 | -26,232 | -9,443 | -35,715 | -34,500 | 71,103 | -37,289 | -25,199 |
其他收入及費用 | 2,199 | 1,960 | -79 | - | 11,960 | -1,544 | 233 | 21,924 | -12,584 | 7,988 |
利息費用 | 2,134 | 2,186 | 2,257 | 2,232 | 2,201 | 2,304 | 2,414 | 2,176 | 1,874 | 1,886 |
稅前純益 | -20,241 | -23,925 | -29,845 | -25,704 | 316 | -39,563 | -36,681 | 90,851 | -51,747 | -19,097 |
所得稅 | - | - | -30 | 37 | 34 | 258 | 15 | 18 | 19 | 33 |
稅後純益 | -20,241 | -23,925 | -29,815 | -25,741 | 282 | -39,821 | -36,696 | 90,833 | -51,766 | -19,130 |
基本每股稅後盈餘(元) | -0.16 | 2.29 | -0.69 | -3.47 | 0.00 | -0.20 | -0.18 | 0.45 | -0.26 | - |
稀釋每股稅後盈餘(元) | -0.16 | 1.00 | -0.69 | -3.47 | 0.00 | -0.20 | -0.18 | 0.45 | -0.26 | -0.09 |
基本平均股數(千股) | 126288.00 | - | 43273.00 | 7412.00 | 205202.00 | 202935.00 | 200867.00 | 200441.00 | 199993.00 | - |
稀釋平均股數(千股) | 126288.00 | - | 43273.00 | 7412.00 | 206072.00 | 202935.00 | 200867.00 | 200802.00 | 199993.00 | - |
還原基本每股稅後盈餘(元) | -0.16 | 2.29 | -0.69 | -3.47 | 0.04 | -6.00 | -5.48 | 13.50 | -7.77 | - |
還原稀釋每股稅後盈餘(元) | -0.16 | 1.00 | -0.69 | -3.47 | 0.04 | -5.94 | -5.40 | 13.47 | -7.77 | -2.67 |
還原基本平均股數(千股) | 126,288 | - | 43,273 | 7,412 | 6,839 | 6,764 | 6,695 | 6,681 | 6,666 | - |
還原稀釋平均股數(千股) | 126,288 | - | 43,273 | 7,412 | 6,868 | 6,764 | 6,695 | 6,693 | 6,666 | - |
EBITDA(千元) | -17,654 | -21,309 | -27,144 | -23,117 | 3,218 | -36,785 | -33,806 | 93,428 | -49,557 | -16,901 |